QuickView for negative regulation of Fas signaling pathway (biogroup)

1. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
2. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
4. B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
5. L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown

There were no matches for negative regulation of Fas signaling pathway

1. Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
2. Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy
3. Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
4. Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration
5. A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis